ℹ️ Compiled from public regulatory records · Last regulator revision: December 12, 2025🚩 Report this page
Bifonazole
Imidazole and Triazole Derivatives
GB MHRA
- Drug class
- Imidazole and Triazole Derivatives
- Availability
- See label
- Markets covered
- 1
- Products on record
- 1
Overview
Bifonazole is an active pharmaceutical ingredient in the Imidazole and Triazole Derivatives group (D01AC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | December 12, 2025 |
GBUnited Kingdom· MHRA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Sources & citations
- [1]MHRA (UK) · PL000100508 · revised December 12, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.